Article information
Full text is only aviable in PDF
References
[1.]
A. Banerjee, E. Dubnau, A. Quemard, et al.
inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis.
Science, 263 (1994), pp. 227-230
[2.]
H. Lee, S.N. Cho, H.E. Bang, et al.
Exclusive mutations related to isoniazid and ethionamide resistance among Mycobacterium tuberculosis isolates from Korea.
Int J Tuberc Lung Dis, 4 (2000), pp. 441-447
[3.]
C. Abe, I. Kobayashi, S. Mitarai, et al.
Biological and molecular characteristics of Mycobacterium tuberculosis clinical isolates with low-level resistance to isoniazid in Japan.
J Clin Microbiol, 46 (2008), pp. 2263-2268
[4.]
G.P. Morlock, B. Metchock, D. Sikes, et al.
ethA, inhA, and katG loci of ethionamide-resistant clinical Mycobacterium tuberculosis isolates.
Antimicrob Ag Chemother, 47 (2003), pp. 3799-3805
[5.]
Standard Operating Procedure for Mycobacteriology Laboratory. Tuberculosis Research Centre (ICMR), Chennai. 2010. (Version 1.1). http://www.trc-chennai.org/pdf/sop.pdf
[6.]
R.V. Chowgule, L. Deodhar.
Pattern of secondary acquired drug resistance to antituberculosis drug in Mumbai, India-1991–1995.
Indian J Chest Dis Allied Sci, 40 (1998), pp. 23-31
[7.]
C.N. Paramasivan, F. Rehman, F. Wares, et al.
First- and secondline drug resistance patterns among previously treated tuberculosis patients in India.
Int J Tuberc Lung Dis, 14 (2010), pp. 243-246
[8.]
R. Ramachandran, S. Nalini, V. Chandrasekar, et al.
Surveillance of drug-resistant tuberculosis in the state of Gujarat, India.
Int J Tuberc Lung Dis, 13 (2009), pp. 1154-1160
[9.]
M.J. Lefford, D.A. Mitchison.
Comparison of methods for testing the sensitivity of Mycobacterium tuberculosis to ethionamide.
Tubercle, 47 (1966), pp. 250-261
[10.]
C. Vilcheze, T.R. Weisbrod, B. Chen, et al.
Altered NADH/NAD+ ratio mediates coresistance to isoniazid and ethionamide in mycobacteria.
Antimicrob Ag Chemother, 49 (2005), pp. 708-720
Copyright © 2011. Elsevier Editora Ltda.. All rights reserved
